HUP0102622A2 - Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them - Google Patents
Biphenyl derivatives, process for producing them and pharmaceutical compositions containing themInfo
- Publication number
- HUP0102622A2 HUP0102622A2 HU0102622A HUP0102622A HUP0102622A2 HU P0102622 A2 HUP0102622 A2 HU P0102622A2 HU 0102622 A HU0102622 A HU 0102622A HU P0102622 A HUP0102622 A HU P0102622A HU P0102622 A2 HUP0102622 A2 HU P0102622A2
- Authority
- HU
- Hungary
- Prior art keywords
- producing
- pharmaceutical compositions
- compositions containing
- biphenyl derivatives
- biphenyl
- Prior art date
Links
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98113488 | 1998-07-20 | ||
PCT/EP1999/004803 WO2000005225A1 (en) | 1998-07-20 | 1999-07-08 | Biphenyl derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0102622A2 true HUP0102622A2 (en) | 2001-12-28 |
HUP0102622A3 HUP0102622A3 (en) | 2002-12-28 |
Family
ID=8232308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0102622A HUP0102622A3 (en) | 1998-07-20 | 1999-07-08 | Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1098892A1 (en) |
JP (1) | JP2002521377A (en) |
KR (1) | KR20010070997A (en) |
CN (1) | CN1309654A (en) |
AR (1) | AR019415A1 (en) |
AU (1) | AU5033899A (en) |
BR (1) | BR9912299A (en) |
CA (1) | CA2338209A1 (en) |
HU (1) | HUP0102622A3 (en) |
ID (1) | ID27846A (en) |
NO (1) | NO20010333D0 (en) |
PL (1) | PL345283A1 (en) |
SK (1) | SK492001A3 (en) |
WO (1) | WO2000005225A1 (en) |
ZA (1) | ZA200101379B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030059244A (en) * | 2000-11-14 | 2003-07-07 | 메르크 파텐트 게엠베하 | Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors |
CA2432642A1 (en) | 2000-12-21 | 2002-08-08 | Subhash P. Khanapure | Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
AU2002303061B2 (en) * | 2001-05-11 | 2009-01-29 | Biovitrum Ab (Publ) | Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders |
CN101851173A (en) | 2001-09-14 | 2010-10-06 | 梅特希尔基因公司 | Inhibitors of histone deacetylase |
SE0103644D0 (en) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic isoquinoline compounds |
CA2575359A1 (en) | 2004-07-28 | 2006-02-02 | Glaxo Group Limited | Piperazine derivatives useful for the treatment of gastrointestinal disorders |
KR101315192B1 (en) * | 2004-10-14 | 2013-10-10 | 애보트 게엠베하 운트 콤파니 카게 | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
WO2007077457A2 (en) * | 2006-01-06 | 2007-07-12 | The Royal Veterinary College | Treatment of equine laminitis with 5-ht1b/ 1d antagonists |
JP2009531385A (en) | 2006-03-31 | 2009-09-03 | グラクソ グループ リミテッド | Piperazine derivatives as growth hormone secretagogue (GHS) receptor agonists |
MX2008013206A (en) | 2006-04-19 | 2008-10-22 | Abbott Gmbh & Co Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor. |
TW200812961A (en) * | 2006-04-19 | 2008-03-16 | Abbott Gmbh & Co Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
CN101432261A (en) | 2006-05-19 | 2009-05-13 | 惠氏公司 | N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
AU2008231789A1 (en) | 2007-03-23 | 2008-10-02 | Abbott Gmbh & Co. Kg | Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
CA2690091A1 (en) | 2007-06-05 | 2008-12-11 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
AR066911A1 (en) | 2007-06-08 | 2009-09-23 | Janssen Pharmaceutica Nv | PIPERIDINE / PIPERAZINE DERIVATIVES |
WO2008148851A1 (en) | 2007-06-08 | 2008-12-11 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
JP5443342B2 (en) | 2007-06-08 | 2014-03-19 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Piperidine / piperazine derivatives |
JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine/Piperazine derivatives |
JP5579170B2 (en) | 2008-06-05 | 2014-08-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Pharmaceutical combination comprising a DGAT inhibitor and a PPAR agonist |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9119920D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
ATE204262T1 (en) * | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | BENZANILIDE DERIVATIVES AS 5-HT1D ANTAGONISTS |
GB2273930A (en) * | 1992-12-30 | 1994-07-06 | Glaxo Group Ltd | Benzanilide derivatives |
GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-07-08 HU HU0102622A patent/HUP0102622A3/en unknown
- 1999-07-08 ID IDW20010307A patent/ID27846A/en unknown
- 1999-07-08 CA CA002338209A patent/CA2338209A1/en not_active Abandoned
- 1999-07-08 JP JP2000561181A patent/JP2002521377A/en active Pending
- 1999-07-08 SK SK49-2001A patent/SK492001A3/en unknown
- 1999-07-08 EP EP99934632A patent/EP1098892A1/en not_active Withdrawn
- 1999-07-08 AU AU50338/99A patent/AU5033899A/en not_active Abandoned
- 1999-07-08 BR BR9912299-5A patent/BR9912299A/en not_active Application Discontinuation
- 1999-07-08 PL PL99345283A patent/PL345283A1/en unknown
- 1999-07-08 WO PCT/EP1999/004803 patent/WO2000005225A1/en not_active Application Discontinuation
- 1999-07-08 CN CN99808739A patent/CN1309654A/en active Pending
- 1999-07-08 KR KR1020017000849A patent/KR20010070997A/en not_active Application Discontinuation
- 1999-07-16 AR ARP990103510A patent/AR019415A1/en not_active Application Discontinuation
-
2001
- 2001-01-19 NO NO20010333A patent/NO20010333D0/en unknown
- 2001-02-19 ZA ZA200101379A patent/ZA200101379B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9912299A (en) | 2001-11-20 |
JP2002521377A (en) | 2002-07-16 |
NO20010333L (en) | 2001-01-19 |
PL345283A1 (en) | 2001-12-03 |
AU5033899A (en) | 2000-02-14 |
SK492001A3 (en) | 2001-08-06 |
KR20010070997A (en) | 2001-07-28 |
EP1098892A1 (en) | 2001-05-16 |
NO20010333D0 (en) | 2001-01-19 |
WO2000005225A1 (en) | 2000-02-03 |
ZA200101379B (en) | 2002-05-20 |
CN1309654A (en) | 2001-08-22 |
CA2338209A1 (en) | 2000-02-03 |
ID27846A (en) | 2001-04-26 |
AR019415A1 (en) | 2002-02-20 |
HUP0102622A3 (en) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900120A3 (en) | Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9802422A3 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0000748A3 (en) | 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0102084A3 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0103224A3 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0002893A3 (en) | Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0001802A3 (en) | Pyrazine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0102622A3 (en) | Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0003608A3 (en) | Tetrahydroisoquinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9901739A3 (en) | Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them | |
HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
HK1039122A1 (en) | Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
HUP9802121A3 (en) | Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9801423A3 (en) | Chromene derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9800865A3 (en) | Condensed piperidine-derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0105479A3 (en) | Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0201785A3 (en) | Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them | |
HUP0103316A3 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
HUP0101234A3 (en) | Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof | |
HUP0100432A3 (en) | Pyridyle derivatives as antivirals, process for producing them and pharmaceutical compositions containing them | |
HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them | |
HUP0003766A3 (en) | Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0104202A3 (en) | Thiazole-derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0201916A3 (en) | Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them | |
HU9601331D0 (en) | New piperazine- and homeopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them |